<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1d0e7c428">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>Senate</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>BILLS</collectionCode>
         <searchTitle>To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.;Ensuring Pathways to Innovative Cures Act of 2025;EPIC Act of 2025;S. 832 (IS)
    </searchTitle>
         <category>Bills and Statutes</category>
         <waisDatabaseName>119_cong_bills</waisDatabaseName>
         <branch>legislative</branch>
         <dateIngested>2025-03-20</dateIngested>
    </extension>
    <titleInfo>
         <title>To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>Ensuring Pathways to Innovative Cures Act of 2025</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>EPIC Act of 2025</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>S. 832 (IS)
    </title>
    </titleInfo>
    <originInfo>
         <publisher>U.S. Government Publishing Office</publisher>
         <dateIssued encoding="w3cdtf">2025-03-04</dateIssued>
         <issuance>monographic</issuance>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>2 p.</extent>
    </physicalDescription>
    <classification authority="sudocs">Y 1.6:</classification>
    <classification authority="sudocs">Y 1.4/1:</classification>
    <identifier type="local">P0b002ee1d0e7c428</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/BILLS-119s832is</identifier>
    <identifier type="preferred citation">S. 832</identifier>
    <identifier type="stock number">021-610-00252-9</identifier>
    <identifier type="Parent ILS system id">000501532</identifier>
    <identifier type="Child ILS system id">000325576</identifier>
    <identifier type="Parent ILS title">Congressional bills</identifier>
    <identifier type="Child ILS title">Senate bills</identifier>
    <identifier type="former package identifier">f:s832_is.txt</identifier>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/BILLS-119s832is</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119s832is/html/BILLS-119s832is.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119s832is/pdf/BILLS-119s832is.pdf</url>
         <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119s832is/xml/BILLS-119s832is.xml</url>
    </location>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2025-03-20</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2025-03-21</recordChangeDate>
         <recordIdentifier source="DGPO">BILLS-119s832is</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <name type="personal">
         <namePart>Thom Tillis</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm authority="marcrelator" type="text">sponsor</roleTerm>
              <roleTerm authority="marcrelator" type="code">spn</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Ted Budd</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Marsha Blackburn</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Steve Daines</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>James Lankford</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>Senate</namePart>
         <namePart>Committee on Finance</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 42 Section 1320f-1(e)(1)(A)(ii)</partNumber>
        </titleInfo>
         <identifier type="USC citation">42 U.S.C. 1320f-1(e)(1)(A)(ii)</identifier>
    </relatedItem>
    <extension>
         <docClass>s</docClass>
         <accessId>BILLS-119s832is</accessId>
         <congress>119</congress>
         <session>1</session>
         <originChamber>SENATE</originChamber>
         <currentChamber>SENATE</currentChamber>
         <billNumber>832</billNumber>
         <billVersion reprint="false">is</billVersion>
         <fileSuffix>is</fileSuffix>
         <shortTitle type="measure">Ensuring Pathways to Innovative Cures Act of 2025</shortTitle>
         <shortTitle type="measure">EPIC Act of 2025</shortTitle>
         <officialTitle>To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.</officialTitle>
         <action date="2025-03-04">Mr. Tillis (for himself, Mr. Budd, Mrs. Blackburn, Mr. Daines, and Mr. Lankford) introduced the following bill; which was read twice and referred to the Committee on Finance</action>
         <congCommittee authorityId="ssfi00" chamber="S" congress="119" type="S">
                                
              <name type="authority-standard">Committee on Finance</name>
                                
              <name type="authority-short">Finance</name>
                            
        </congCommittee>
         <congMember bioGuideId="T000476" chamber="S" congress="119" party="R" role="SPONSOR" state="NC">
                                
              <name type="parsed">Mr. Tillis</name>
                                
              <name type="authority-fnf">Thom Tillis</name>
                                
              <name type="authority-lnf">Tillis, Thomas</name>
                                
              <name type="authority-other">Mr. Thomas Roland Tillis</name>
                            
        </congMember>
         <congMember bioGuideId="B001305" chamber="S" congress="119" party="R" role="COSPONSOR" state="NC">
                                
              <name type="parsed">Mr. Budd</name>
                                
              <name type="authority-fnf">Ted Budd</name>
                                
              <name type="authority-lnf">Budd, Ted</name>
                            
        </congMember>
         <congMember bioGuideId="B001243" chamber="S" congress="119" party="R" role="COSPONSOR" state="TN">
                                
              <name type="parsed">Mrs. Blackburn</name>
                                
              <name type="authority-fnf">Marsha Blackburn</name>
                                
              <name type="authority-lnf">Blackburn, Marsha</name>
                            
        </congMember>
         <congMember bioGuideId="D000618" chamber="S" congress="119" party="R" role="COSPONSOR" state="MT">
                                
              <name type="parsed">Mr. Daines</name>
                                
              <name type="authority-fnf">Steve Daines</name>
                                
              <name type="authority-lnf">Daines, Steve</name>
                            
        </congMember>
         <congMember bioGuideId="L000575" chamber="S" congress="119" party="R" role="COSPONSOR" state="OK">
                                
              <name type="parsed">Mr. Lankford</name>
                                
              <name type="authority-fnf">James Lankford</name>
                                
              <name type="authority-lnf">Lankford, James</name>
                            
        </congMember>
         <isPrivate>false</isPrivate>
         <isAppropriation>false</isAppropriation>
         <USCode title="42">
                                
              <section detail="(e)(1)(A)(ii)" number="1320f-1"></section>
                            
        </USCode>
    </extension>
</mods>